GABA Transporter 1 (GAT1) (Middle Region) Peptide
GAT1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN984038
Quick Overview for GABA Transporter 1 (GAT1) (Middle Region) Peptide (ABIN984038)
Target
SLC6A1 (GAT1)
(GABA Transporter 1 (GAT1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- LIILFFRGVT LPGAKEGILF YITPNFRKLS DSEVWLDAAT QIFFSYGLGL
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-SLC6A1 Antibody(ARP43833_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SLC6A1 (GAT1) (GABA Transporter 1 (GAT1))
-
Background
-
SLC6A1 terminates the action of GABA by its high affinity sodium-dependent reuptake into presynaptic terminals. This protein is the target of psychomotor stimulants such as amphetamines or cocaine.
Alias Symbols: GABATHG, GABATR, GAT1
Protein Interaction Partner: STX1A,STX1A
Protein Size: 599 -
Molecular Weight
- 67 kDa
-
Gene ID
- 6529
-
NCBI Accession
- NM_003042, NP_003033
-
UniProt
- P30531
Target
-
You are here:
